SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-10-239363
Filing Date
2010-10-28
Accepted
2010-10-28 12:46:17
Documents
12
Period of Report
2010-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 592788
2 FORM OF 2007 EQUITY INCENTIVE PLAN RESTRICTED STOCK AWARD AGREEMENT - DIRECTORS dex106.htm EX-10.6 42372
3 FORM OF 2007 EQUITY INCENTIVE PLAN RESTRICTED STOCK AWARD AGREEMENT - EMPLOYEES dex107.htm EX-10.7 43176
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 dex311.htm EX-31.1 7491
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 dex312.htm EX-31.2 7663
6 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER dex32.htm EX-32 7155
  Complete submission text file 0001193125-10-239363.txt   2261523

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT ctic-20100930.xml EX-101.INS 156333
8 XBRL TAXONOMY EXTENSION SCHEMA ctic-20100930.xsd EX-101.SCH 21050
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ctic-20100930_cal.xml EX-101.CAL 53160
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctic-20100930_def.xml EX-101.DEF 102001
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctic-20100930_lab.xml EX-101.LAB 126982
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctic-20100930_pre.xml EX-101.PRE 109874
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062827100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12465 | Film No.: 101147194
SIC: 2834 Pharmaceutical Preparations